http://www.bioethicsinternational.org/blog/2008/09/24/supreme-court-case-wyeth-v-levine-the-preemption-temptation/ Where Healthcare, Life Science & Ethics Meet Sat, 27 Feb 2010 03:30:51 -0700 http://wordpress.org/?v=2.8.5 hourly 1 http://www.bioethicsinternational.org/blog/2008/09/24/supreme-court-case-wyeth-v-levine-the-preemption-temptation/comment-page-1/#comment-22588 Supreme Court Case Wyeth v. Levine & the Preemption Temptation | OncoBlog.com Fri, 31 Oct 2008 23:56:57 +0000 http://www.bioethicsinternational.org/?p=628#comment-22588 [...] Originally posted here:  Supreme Court Case Wyeth v. Levine & the Preemption Temptation [...] [...] Originally posted here:  Supreme Court Case Wyeth v. Levine & the Preemption Temptation [...]

]]> http://www.bioethicsinternational.org/blog/2008/09/24/supreme-court-case-wyeth-v-levine-the-preemption-temptation/comment-page-1/#comment-22580 Drugmakers could win lawsuit limits at top court | OncoBlog.com Fri, 31 Oct 2008 22:18:27 +0000 http://www.bioethicsinternational.org/?p=628#comment-22580 [...] The case at the Supreme Court is Wyeth v. Levine. [...] [...] The case at the Supreme Court is Wyeth v. Levine. [...]

]]> http://www.bioethicsinternational.org/blog/2008/09/24/supreme-court-case-wyeth-v-levine-the-preemption-temptation/comment-page-1/#comment-22086 Anthony C. Coveny, Ph.D., JD, MA Thu, 23 Oct 2008 18:07:26 +0000 http://www.bioethicsinternational.org/?p=628#comment-22086 I applaud your editorial. The conservative Court would have to be very activist indeed to strip plaintiffs of their right to sue under state law. Congress put nothing into FDCA that would constitute its intent that preemption apply across the board to shield drug companies from responsibility for warning the public and medical personnel of the deleterious impact of their products. This is especially true as it is the drug company that provides most of the information to the FDA to make its determination. I applaud your editorial. The conservative Court would have to be very activist indeed to strip plaintiffs of their right to sue under state law. Congress put nothing into FDCA that would constitute its intent that preemption apply across the board to shield drug companies from responsibility for warning the public and medical personnel of the deleterious impact of their products. This is especially true as it is the drug company that provides most of the information to the FDA to make its determination.

]]> http://www.bioethicsinternational.org/blog/2008/09/24/supreme-court-case-wyeth-v-levine-the-preemption-temptation/comment-page-1/#comment-20942 This week’s Top Biotech Bioethics News: Pfizer’s stem cell ventures, Eli Lilly’s DR payment disclosures, & Supreme Court Case Wyeth v. Levine’s Preemption Temptation « Blogging Biotech Wed, 01 Oct 2008 17:54:00 +0000 http://www.bioethicsinternational.org/?p=628#comment-20942 [...] Of other interest, next month the Supreme Court will hear arguments for Wyeth v. Levine, pertaining to whether manufacturers complying with FDA stipulated warning requirements can be held liable under state tort law for not supplying adequate warnings. click here to continue reading. [...] [...] Of other interest, next month the Supreme Court will hear arguments for Wyeth v. Levine, pertaining to whether manufacturers complying with FDA stipulated warning requirements can be held liable under state tort law for not supplying adequate warnings. click here to continue reading. [...]

]]>